Clinical Trial Update: Design Validation of Senofilcon A With New UV-blocking Additive [NA]

View source ↗

Summary

A completed clinical trial evaluating a senofilcon A contact lens with a new UV-blocking additive in relation to visual acuity; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visual Acuity Impairment

Drugs mentioned

• Senofilcon A

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Acuity | NA | Status: COMPLETED | Results posted: 2019-12-05